Mechanisms of Fingolimods Efficacy and Adverse Effects in Multiple SclerosisAnn Neurol 69:759-777, Cohen, J.A. & Chun, J., 2011
Gray Matter Involvement in Multiple SclerosisNeurol 68:634-642, Pirko,I.,et al, 2007